PeerView | Otolaryngology

Free CME from PeerView

Otolaryngology CME

Credits: 1.0 CME / CC

PVI, PeerView Institute for Medical Education

Refining Best Practices in Cancer Immunotherapy Biomarker Testing and Pathologic Response Assessment

Janis Taube, MD, MSc

March 02, 2023

Credits: 1.0 CME / MOC / NCPD / CPE

PVI, PeerView Institute for Medical Education

Toward a Goal of Breathing Easy: Identifying Which of Your Patients With Chronic Rhinosinusitis With Nasal Polyps Can Benefit From Targeted Biologic Therapy

Anju T. Peters, MD, MS

October 07, 2022

Credits: 0.5 CME

PVI, PeerView Institute for Medical Education

Room to Breathe: Leveraging Biologic Agents and Multidisciplinary Care to Optimize Management in Chronic Rhinosinusitis With Nasal Polyps

Jivianne T. Lee, MD, FACS

September 28, 2022

Credits: 0.5 CME / MOC

PVI, PeerView Institute for Medical Education

Optimizing NTRK Fusion Testing and TRK Inhibition in Thyroid Cancer: Team-Based Approaches for Enhanced Outcomes

Marcia S. Brose, MD, PhD, FASCO

September 26, 2022

Credits: 1.0 CME / MOC / NCPD / ILNA

PVI, PeerView Institute for Medical Education

Uncovering Gene Fusions & Other Key Genomic Alterations in Lung, Thyroid, Colon, Breast, and Other Solid Tumors to Enable All Patients to Gain the Full Benefits of Targeted Treatment

Alexander Drilon, MD

August 16, 2022

Credits: 1.5 CME / MOC

PVI, PeerView Institute for Medical Education

The Power and Promise of Immunotherapy in Head and Neck Cancer: How Established and Emerging Immune-Based Options Can Enhance Patient Care

Robert I. Haddad, MD

June 05, 2022

Medical Learning Institute, Inc.

Evolving Standards in Biomarker Testing, Scoring, and Results Interpretation Driven by the Broadening Role of Cancer Immunotherapy

Kurt A. Schalper, MD, PhD

September 29, 2021

Purdue University College of Pharmacy

Analyzing the Pros and Cons of Standard and Alternative Dosing Regimens of Immunotherapies and Combinations in Modern Oncology Practice

Evan J. Lipson, MD

May 11, 2021

Medical Learning Institute, Inc.

The Nuances of Immunotherapy Biomarker Testing in Solid Tumors: Unraveling Complexities and Overcoming Challenges to Improve Outcomes

Hossein Borghaei, DO, MS / Sanjay Mukhopadhyay, MD

April 05, 2021